Relmada Therapeutics shares owned by Palo Alto Investors
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Palo Alto Investors
from 13F filings
Historical chart of Palo Alto Investors investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Palo Alto Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 732k | 4.14 |
| 2023-09-30 | $2.2M | 732k | 3.00 |
| 2023-06-30 | $1.8M | 732k | 2.46 |
| 2023-03-31 | $1.2M | 542k | 2.26 |